Skip to main content
Premium Trial:

Request an Annual Quote

Joe DeRisi, Tom Tuschl, Greg Hannon, Evan Eichler, Stephen Quake, Jason Alter

Premium

The Howard Hughes Medical Institute has named 43 new HHMI investigators, chosen from almost 300 proposals in a nationwide competition. Among the new HHMI investigators are microbial microarray pioneer Joe DeRisi, an associate professor of biochemistry at the University of California, San Francisco; RNAi researchers Tom Tuschl, an associate professor at Rockefeller University, and Greg Hannon, a professor at Cold Spring Harbor Laboratory; Evan Eichler, an associate professor of genome sciences at the University of Washington in Seattle; and Stephen Quake, a professor of bioengineering at Stanford University.


Vance Wheelock has joined BioAnalyte to “consult on e-commerce solutions” and to advise the company on selling its proNets and pepNets licenses, which permit analytical instrument users to process datasets using the company’s Trawler products on a per-dataset basis. Wheelock co-founded the Maine Linux User Group in 1995, and founded the Southern Maine Linux Users Group in 2000. Until last fall, Wheelock was the lead web developer for Blue Marble Geographics, a mapping software company.


TurboWorx has tapped Jason Alter as its new director of marketing. Alter joins TurboWorx from IBM, where he was most recently manager of program marketing for the Healthcare and Life Sciences business unit. Prior to that, he held a number of marketing roles at IBM Life Sciences.

Filed under

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.